School of Medicine
Showing 1-10 of 14 Results
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Bio After graduating from Brown Medical School, Dr. Lahijani completed the Combined Internal Medicine/Psychiatry Residency Program at Rush University Medical Center in Chicago. She then served as a physician in the areas of primary care and triple diagnosis (addiction, HIV, mental health).
Thereafter, Dr. Lahijani completed the Psychosomatic Medicine Fellowship at the Feinberg School of Medicine of Northwestern University where she worked at the Lurie Comprehensive Cancer Center. During her fellowship, she also served as a psycho-oncologist at Memorial Sloan Kettering Cancer Center. Dr. Lahijani is trained in and administers different psychotherapeutic modalities, including Meaning Centered Psychotherapy and Dignity Therapy.
Dr. Lahijani joined the faculty of Stanford University School of Medicine in 2015 as a Clinical Assistant Professor of Psychiatry and Behavioral Sciences. Since her initial appointment, Dr. Lahijani has served as the lead psychiatric oncologist at the Stanford Cancer Center where she has provided psychiatric consultation services to patients with cancer and collaborated closely with her hematology and oncology colleagues to deliver comprehensive cancer care.
In 2019, she was appointed as the Medical Director of the Stanford Cancer Center Psychosocial Oncology Program where she works directly with Stanford Cancer Center leadership and oversees the development and operationalization of psychiatric consultation for patients with cancer. Dr. Lahijani also attends on the inpatient Consultation Liaison Psychiatry Service at Stanford Hospital and Clinics to provide care for all patients with complex medical and psychiatric diagnoses and to teach psychiatry, internal medicine, and neurology trainees.
As Faculty of the Advancing Communication Excellence at Stanford, Dr. Lahijani leads foundational workshops for faculty and staff to advance communication skills with patients, families, and their colleagues. She is committed to developing and contributing to efforts that focus on relationship centered skills and provider wellness.
Her clinical and scholarly interests include the interface of Medicine and Psychiatry, Psycho-Oncology, collaborative care models, psychotherapy for the medically ill, psychopharmacology, interdisciplinary medical education, teaching, and academic writing.
Laura C. Lazzeroni, Ph.D.
Professor (Research) of Psychiatry and Behavioral Sciences and of Biomedical Data Science
Current Research and Scholarly Interests Statistics/Data Science. I develop & apply models, methods & algorithms for complex data in medical science & biology. I am also interested in the interplay between fundamental statistical properties (e.g. variability, bias, p-values) & how scientists actually use & interpret data. My work in statistical genetics includes: the invention of Plaid bi-clustering for gene expression data; methods for twin, association, & family studies; multiple testing & estimation for high dimensional arrays.
Associate Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult) and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center
Bio Dr. Anna Lembke received her undergraduate degree in Humanities from Yale University and her medical degree from Stanford University. She is currently Associate Professor and Medical Director of Addiction Medicine, Stanford University School of Medicine. She is also Program Director of the Stanford Addiction Medicine Fellowship, and Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. She is a diplomate of the American Board of Psychiatry and Neurology, and a diplomate of the American Board of Addiction Medicine.
Dr. Lembke was one of the first in the medical community to sound the alarm regarding opioid overprescribing and the opioid epidemic. In 2016, she published her best-selling book on the prescription drug epidemic, Drug Dealer, MD ? How Doctors Were Duped, Patients Got Hooked, and Why It?s So Hard to Stop (Johns Hopkins University Press, 2016), which combines case studies with public policy, cultural anthropology, and neuroscience, to explore the complex relationship between doctors and patients around prescribing controlled drugs. Drug Dealer, MD has had an impact on policy makers and legislators across the nation. Dr. Lembke has testified before Congress and consulted with governors and senators from Kentucky to Missouri to Nevada. She was a featured guest on Fresh Air with Terry Gross, MSNBC with Chris Hayes, and numerous other media broadcasts. Her book was highlighted in the New York Times as one of the top five books to read to understand the opioid epidemic (Zuger, 2018). Using her public platform and her faculty position at Stanford University School of Medicine, Dr. Lembke continues to educate policymakers and the public about causes of and solutions for the problem of addiction.
Clinical Instructor, Psychiatry and Behavioral Sciences
Bio Dr. Stacy Lin is a licensed psychologist in the Department of Psychiatry and Behavioral Sciences who provides culturally-informed psychotherapy for the treatment of emotion dysregulation, eating disorders, and trauma. Dr. Lin has specialized training in comprehensive Dialectical Behavior Therapy and Cognitive Behavioral Therapy. She is broadly interested in issues of diversity and inclusion in clinical, training, and professional settings. Her research has examined cultural factors affecting disordered eating and body image in racial/ethnic minorities.
Anne Juliana Lockman
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Bio Dr. Juliana Lockman is Clinical Assistant Professor in the Neuropsychiatry Division in Department of Psychiatry & Behavioral Sciences at Stanford. She is also appointed to La Selva Group, where she directs the Functional Neurologic Symptom Disorder (FND) Track within their state-of-the-art residential, partial hospitalization and intensive outpatient programs. She completed residencies in both Neurology at the University of Virginia and Psychiatry at Stanford Hospital & Clinics. Her clinical activities include providing pharmacologic and behavioral care for clients with psychiatric and behavioral conditions in the context of neurological illness, including epilepsy, stroke, movement disorders and others. She also teaches and supervises Stanford residents and fellows in Neuropsychiatry. Professional goals include advancement of research and clinical care and improving access for clients suffering from neuropsychiatric conditions, including FND and related disorders.